ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 224 filers reported holding ALKERMES PLC in Q2 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $25,927,000 | +19.0% | 1,057,389 | -9.3% | 0.02% | +12.5% |
| Q1 2021 | $21,779,000 | -6.4% | 1,165,883 | -0.0% | 0.02% | -11.1% |
| Q4 2020 | $23,263,000 | +20.4% | 1,166,073 | 0.0% | 0.02% | +5.9% |
| Q3 2020 | $19,322,000 | -14.6% | 1,166,073 | 0.0% | 0.02% | -15.0% |
| Q2 2020 | $22,628,000 | +34.6% | 1,166,073 | +0.1% | 0.02% | +11.1% |
| Q1 2020 | $16,806,000 | -27.1% | 1,165,473 | -0.1% | 0.02% | -5.3% |
| Q4 2019 | $23,046,000 | -0.7% | 1,166,273 | -2.0% | 0.02% | -5.0% |
| Q3 2019 | $23,219,000 | -14.5% | 1,190,091 | -1.2% | 0.02% | -16.7% |
| Q2 2019 | $27,155,000 | -41.7% | 1,204,768 | -5.6% | 0.02% | -41.5% |
| Q1 2019 | $46,559,000 | +24.6% | 1,275,948 | +0.8% | 0.04% | +7.9% |
| Q4 2018 | $37,359,000 | -30.6% | 1,265,969 | -0.2% | 0.04% | -17.4% |
| Q3 2018 | $53,817,000 | +3.1% | 1,268,075 | +0.0% | 0.05% | +7.0% |
| Q2 2018 | $52,192,000 | -30.1% | 1,268,025 | -1.6% | 0.04% | -38.6% |
| Q1 2018 | $74,675,000 | +5.9% | 1,288,387 | +0.0% | 0.07% | +7.7% |
| Q4 2017 | $70,512,000 | +7.6% | 1,288,357 | -0.0% | 0.06% | +3.2% |
| Q3 2017 | $65,520,000 | -12.6% | 1,288,758 | -0.4% | 0.06% | -14.9% |
| Q2 2017 | $74,982,000 | -1.3% | 1,293,462 | -0.4% | 0.07% | -2.6% |
| Q1 2017 | $75,992,000 | +5.3% | 1,299,017 | +0.0% | 0.08% | -3.8% |
| Q4 2016 | $72,192,000 | +18.2% | 1,298,881 | +0.0% | 0.08% | +14.5% |
| Q3 2016 | $61,082,000 | +8.4% | 1,298,781 | -0.4% | 0.07% | +3.0% |
| Q2 2016 | $56,369,000 | -9.0% | 1,304,243 | -28.0% | 0.07% | -9.5% |
| Q1 2016 | $61,965,000 | -61.1% | 1,812,377 | -9.6% | 0.07% | -59.8% |
| Q4 2015 | $159,202,000 | +29.7% | 2,005,574 | -4.1% | 0.18% | +25.2% |
| Q3 2015 | $122,751,000 | -8.0% | 2,092,232 | +0.9% | 0.15% | +4.3% |
| Q2 2015 | $133,450,000 | +12.3% | 2,074,137 | +6.4% | 0.14% | +14.6% |
| Q1 2015 | $118,814,000 | +1.2% | 1,948,733 | -2.8% | 0.12% | 0.0% |
| Q4 2014 | $117,373,000 | +37.3% | 2,004,324 | +0.5% | 0.12% | +30.9% |
| Q3 2014 | $85,509,000 | -9.0% | 1,994,616 | +6.9% | 0.09% | -11.3% |
| Q2 2014 | $93,933,000 | +38.7% | 1,866,337 | +21.5% | 0.11% | +32.5% |
| Q1 2014 | $67,720,000 | +29.6% | 1,535,940 | +19.5% | 0.08% | +23.1% |
| Q4 2013 | $52,259,000 | +22.9% | 1,285,270 | +1.6% | 0.06% | +10.2% |
| Q3 2013 | $42,521,000 | +17.2% | 1,264,740 | 0.0% | 0.06% | +7.3% |
| Q2 2013 | $36,273,000 | – | 1,264,740 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 8,964,640 | $234,246,043 | 27.88% |
| Krensavage Asset Management, LLC | 1,401,783 | $36,629 | 11.32% |
| Hardman Johnston Global Advisors LLC | 5,561,806 | $145,329,991 | 5.69% |
| 13D Management LLC | 383,584 | $10,023,050 | 5.27% |
| Prosight Management, LP | 341,521 | $8,923,944 | 4.87% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $15,483,230 | 4.78% |
| Tamarack Advisers, LP | 275,000 | $7,185,750 | 3.70% |
| Ally Bridge Group (NY) LLC | 142,002 | $3,710,512 | 3.61% |
| HealthCor Management, L.P. | 110,000 | $2,874,300 | 2.63% |
| Price Jennifer C. | 360,600 | $9,422,478 | 2.25% |